GREAT WEST LIFE ASSURANCE CO /CAN/ – Vertex Pharmaceuticals Incorporated Transaction History
GREAT WEST LIFE ASSURANCE CO /CAN/ portfolio value:
$86.21M
portfolio value
GREAT WEST LIFE ASSURANCE CO /CAN/ quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.41% | -1.21K shares | 1.75M | $289.54 | 298.23K |
| Q2 2022 | share | Decrease | -25.19% | -100.83K shares | -25.95M | $281.79 | 299.45K |
| Q1 2022 | share | Decrease | -1.31% | -5.32K shares | 21.56M | $260.97 | 400.29K |
| Q4 2021 | share | Increase | +4.12% | 16.03K shares | 17.69M | $222.45 | 405.62K |
| Q3 2021 | share | Increase | +0.26% | 1.01K shares | -7.17M | $181.39 | 389.58K |
| Q2 2021 | share | Increase | +36.32% | 103.52K shares | 17.43M | $201.63 | 388.57K |
| Q1 2021 | share | Decrease | -15.76% | -53.33K shares | -18.94M | $214.89 | 285.05K |
| Q4 2020 | share | Increase | +7.42% | 23.38K shares | -3.96M | $236.34 | 338.38K |
| Q3 2020 | share | Increase | +8.82% | 25.53K shares | 52K | $272.12 | 315.00K |
| Q2 2020 | share | Increase | +9.76% | 25.74K shares | 20.63M | $290.31 | 289.46K |
| Q1 2020 | share | Decrease | -3.22% | -8.77K shares | 3.91M | $237.95 | 263.72K |
| Q4 2019 | share | Increase | +20.97% | 47.23K shares | 20.98M | $218.95 | 272.49K |
| Q3 2019 | share | Decrease | -1.48% | -3.37K shares | -3.69M | $169.42 | 225.26K |
| Q2 2019 | share | Increase | +4.71% | 10.28K shares | 1.83M | $183.38 | 228.64K |
| Q1 2019 | share | Increase | +14.49% | 27.62K shares | 9.68M | $183.95 | 218.35K |
| Q4 2018 | share | Decrease | -1.06% | -2.03K shares | -6.82M | $165.71 | 190.72K |
| Q3 2018 | share | Decrease | -10.79% | -23.31K shares | 444K | $192.74 | 192.76K |
| Q2 2018 | share | Increase | +0.95% | 2.04K shares | 1.83M | $169.96 | 216.08K |
| Q1 2018 | share | Decrease | -3.14% | -6.94K shares | 1.83M | $162.98 | 214.03K |
| Q4 2017 | share | Increase | +0.71% | 1.55K shares | 188K | $149.86 | 220.98K |
| Q3 2017 | share | Decrease | -4.47% | -10.26K shares | 3.33M | $152.04 | 219.43K |
| Q2 2017 | share | Increase | +30.87% | 54.17K shares | 10.38M | $128.87 | 229.69K |
| Q1 2017 | share | Increase | +0.74% | 1.28K shares | 6.29M | $109.35 | 175.51K |
| Q4 2016 | share | Decrease | -1.18% | -2.07K shares | -2.48M | $73.67 | 174.23K |
| Q3 2016 | share | Increase | +3.00% | 5.14K shares | 676K | $87.21 | 176.30K |
| Q2 2016 | share | Increase | +31.36% | 40.86K shares | 4.34M | $86.02 | 171.16K |
| Q1 2016 | share | Increase | +4.45% | 5.55K shares | -5.35M | $79.49 | 130.29K |